You are here

Articles

EUTOS Score Validated for Predicting Treatment Outcomes With TKI Therapy

published: 15 July 2013

'CML Horizons' 2013 Report

published: 5 July 2013

Europe Approves Ponatinib as Orphan Drug for Leukemias -

published: 3 July 2013

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

published: 1 July 2013

"Treating Chronic Myeloid Leukemia Improving Management through understanding the patient experiences"

published: 17 June 2013

Landmark analysis of 4-year (y) data from ENESTnd.

published: 12 June 2013

Plasma trough imatinib levels and molecular response in patients with CML: A single institution study from India.

published: 12 June 2013

How I Manage: Chronic Myeloid Leukemia by Jerald Radich, MD

published: 5 June 2013

Targeting of the MNK–eIF4E axis in blast crisis CML inhibits leukemia stem cell function

published: 5 June 2013

population study shows the advent of 2ndGen TKIs has improved progression-free survival in CML

published: 1 June 2013

Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML

published: 12 May 2013

Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells

published: 12 May 2013

Price of drugs for chronic myeloid leukemia (CML), reflection of the unsustainable cancer drug prices: perspective of CML Experts

published: 26 April 2013

ESK1-New Monoclonal Antibody Targets Intracellular Oncogenic Proteins in Leukemias

published: 17 April 2013

Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase?

published: 17 April 2013

Nilotinib for CML Leads to Fewer Treatment-Emergent Mutations Than Imatinib

published: 17 April 2013

Chronic Fatigue Limits Quality of Life in Imatinib-Treated CML Patients

published: 17 April 2013

Long-Term Treatment With Imatinib Affected Bone Mineral Density

published: 17 April 2013

Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy

published: 11 April 2013

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies

published: 5 April 2013